{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/vitamin-d-deficiency-in-children/prescribing-information/high-dose-vitamin-d/","result":{"pageContext":{"chapter":{"id":"b484f9f2-fe93-53ca-9ff9-4f0a4c4f4c7d","slug":"high-dose-vitamin-d","fullItemName":"High-dose vitamin D","depth":2,"htmlHeader":"<!-- begin field 5be5aa75-4d85-4474-93fc-498e623dab3c --><h2>High-dose vitamin D </h2><!-- end field 5be5aa75-4d85-4474-93fc-498e623dab3c -->","summary":"","htmlStringContent":"<!-- begin item 2e6f2a3a-a721-4c5a-9155-efb53130121b --><!-- end item 2e6f2a3a-a721-4c5a-9155-efb53130121b -->","topic":{"id":"89d3d3f2-0fb9-5122-8124-8a248851c341","topicId":"6f02f244-d6e1-47d2-9f6e-90aba05fc9ca","topicName":"Vitamin D deficiency in children","slug":"vitamin-d-deficiency-in-children","lastRevised":"Last revised in December 2020","chapters":[{"id":"e4e640d6-bbf5-5522-a672-0b8deafbd735","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"94a73733-1425-56b2-a893-d4a53490d450","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"661f310f-639f-5c8e-a460-568d5c5f6048","fullItemName":"How up-to-date is this topic","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"c56937b4-3157-58c7-bd9a-44f0caed21c6","slug":"changes","fullItemName":"Changes"},{"id":"d6925710-6f4f-59e1-8964-e7227711dc54","slug":"update","fullItemName":"Update"}]},{"id":"b836020c-d6cc-532a-9d4e-3ab2d16e6e4d","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"b06d6ba1-b7cc-5f6b-b6f1-251fab92d88b","slug":"goals","fullItemName":"Goals"},{"id":"43dfe300-848d-5ce3-b9af-f856fc5be1e3","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1a7c671f-a1c3-5d70-8689-3a8a0a282b36","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"0d89edbe-b8d5-5805-bf38-9f05d1381fe5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a9f8eb44-4ca7-53e5-914e-981754c743c0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - options for local implementation"},{"id":"29ee6f63-4681-5df2-8877-f1ab466c5d3c","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"2e1e6cce-1aa3-5384-9076-ff998dc5b68a","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"84e8a128-39b3-5d2f-824f-f064f4940f62","slug":"definition","fullItemName":"Definition"},{"id":"bba9a37f-eed2-5f7c-8d31-0f0c14103a04","slug":"causes","fullItemName":"Causes"},{"id":"efaea96f-7184-5a4d-9212-c0da41e14c61","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"841fe029-27d0-538b-89b8-9a1a8d7aaacd","slug":"prevalence","fullItemName":"Prevalence"},{"id":"8a0ea8cd-f6ee-5914-ba9c-8c7d101922a9","slug":"prognosis","fullItemName":"Prognosis"},{"id":"1202177f-550a-5a45-a9b6-6374dab84692","slug":"complications","fullItemName":"Complications"}]},{"id":"d8163601-9144-52e6-8319-7944e656740f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6b4b4430-c8e8-5f65-9216-81e7837c8450","slug":"who-to-test","fullItemName":"Who to test"},{"id":"57756772-0cb4-504c-b784-d948eb7e460b","slug":"investigations","fullItemName":"Investigations"},{"id":"84459e95-0fef-5876-bf81-4d7b545352b1","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"1effbd00-339f-5303-96d1-6b6352bb4169","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"733f3432-0c2c-58ec-85a4-fa018514d91f","fullItemName":"Management","slug":"management","subChapters":[{"id":"e5d1366b-d7c8-507b-be20-d9e05399c0c0","slug":"management-of-vitamin-d-deficiency-or-insufficiency","fullItemName":"Scenario: Management of vitamin D deficiency or insufficiency"},{"id":"810d5735-b2c5-5c11-84d5-673709a526e8","slug":"prevention-of-vitamin-d-deficiency","fullItemName":"Scenario: Prevention of vitamin D deficiency"}]},{"id":"5fa3fc0f-49fe-5192-b726-15a6bfb93264","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"b484f9f2-fe93-53ca-9ff9-4f0a4c4f4c7d","slug":"high-dose-vitamin-d","fullItemName":"High-dose vitamin D"},{"id":"bf96bac1-28b6-56a4-aad7-728a1208fde0","slug":"calcium-supplements","fullItemName":"Calcium supplements"}]},{"id":"1aa06647-82f6-59c2-8454-0ea6c2d8c2d1","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ada960de-e2ac-5500-b5cb-a16dca8b3a6b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"ec99a548-633b-575f-a6c5-30be6bc0107e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"ff3c8670-d406-5ef9-8c7b-6a38abb4e341","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"98913658-651e-5d94-8750-490c8bbafabf","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"c40a59fc-0923-5f07-b3cb-9b21bdc9d7a5","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"98f6b277-e8d7-57fa-8d2e-4064a4483cd9","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"bd46d532-623e-584d-83d3-fef1dde8f07a","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"5fa3fc0f-49fe-5192-b726-15a6bfb93264","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"68ccec5a-283a-50ec-b7e9-53b9e97c3a7e","slug":"available-products","fullItemName":"Available products","depth":3,"htmlHeader":"<!-- begin field fe3988f6-7f15-4165-80bb-3b70f929bce2 --><h3>What vitamin D preparations are available to treat vitamin D deficiency?</h3><!-- end field fe3988f6-7f15-4165-80bb-3b70f929bce2 -->","summary":"","htmlStringContent":"<!-- begin item d86991db-6f75-45f4-bfe3-651f9930b65a --><!-- begin field 4865f39e-fe76-45f7-8fe8-1ec2892cb61c --><ul><li><strong>There are several high-dose vitamin D preparations available for the treatment of vitamin D deficiency. However, most do not have a UK license.</strong><ul><li>The British National Formulary (BNF) for Children lists the following preparations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-children/references/\">BNF for Children, 2017</a>]:<ul><li>Ergocalciferol (vitamin D<sub>2</sub>) non-proprietary tablets — available in 250 micrograms (10,000 international units [IU]) and 1.25 mg (50,000 IU) tablets.</li><li>Ergocalciferol capsules — available in 1.25 mg (50,000 IU) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-children/references/\">ABPI, 2016a</a>].</li><li>Ergocalciferol intramuscular injection containing 7.5 mg (300,000 IU) of vitamin D<sub>2 </sub>per mL —available in 1 and 2 mL ampoules.</li><li>Fultium-D3<sup>®</sup> (colecalciferol) capsules — available in 20 micrograms (800 IU), 80 micrograms (3200 IU), and 500 micrograms (20,000 IU) capsules.</li><li>Desunin<sup>®</sup> (colecalciferol) tablets — available in 20 micrograms (800 IU) and 100 micrograms (4,000 IU). </li><li>InVita D3® (colecalciferol) oral solution — available in 625 micrograms (25,000 IU) per mL ampoules. </li></ul></li><li>Information on the licensed ages of these products is available in the BNF for Children (<a href=\"http://www.evidence.nhs.uk/\" data-hyperlink-id=\"797f0518-4802-41b8-aa83-a98c014395ab\">www.evidence.nhs.uk</a>) and the manufacturers’ Summaries of Product Characteristics (SPCs, <a href=\"http://www.medicines.org.uk/emc/\" data-hyperlink-id=\"bf631593-2dae-4ff5-8c9e-a98c014395e3\"><u>www.medicines.org.uk</u></a>).</li></ul></li><li><strong>Unlicensed formulations of vitamin D preparations, including colecalciferol liquid 3000 units per mL, are available from 'special-order' manufacturers and specialist importing companies.</strong><ul><li>The East and South East England Specialist Pharmacy Services document <a href=\"https://www.sps.nhs.uk/wp-content/uploads/2014/08/fileMDs3Nzg2ODU7L3VwbG9hZC9kb2N1bWVudHMvQ29tbXVuaXRpZXMvU1BTX0VfU0VfRW5nbGFuZC9WaXRhbWluIEQgcHJvZHVjdCBhdmFpbGFiaWxpdHkgQXVnIDIwMTQucGRm.pdf\" data-hyperlink-id=\"da92c16a-01bc-426f-ab26-a98c01439668\">Vitamin D deficiency and Insufficiency: using appropriate available products </a>has a comprehensive (but not exhaustive) list of available vitamin D products, including unlicensed products.</li></ul></li><li><strong>For people with peanut or soya allergy,</strong> see the UK Medicines Information (UKMi) document <a href=\"http://www.evidence.nhs.uk/search?q=%22Is+there+a+suitable+vitamin+D+product+for+a+patient+with+a+peanut+or+soya+allergy%22\" data-hyperlink-id=\"c08a5c0f-1b7b-4ca5-80c3-a98c01439690\">Is there a suitable vitamin D product for a patient with a peanut or soya allergy?</a>, available on the NICE Evidence website (<a href=\"http://www.evidence.nhs.uk/search?q=%22Is+there+a+suitable+vitamin+D+product+for+a+patient+with+a+peanut+or+soya+allergy%22\" data-hyperlink-id=\"0514ca27-ac46-4798-926d-a98c0143974f\">www.evidence.nhs.uk</a>), for information on suitable peanut and soya-free vitamin D preparations.</li><li><strong>For people on a vegetarian or vegan diet,</strong> see the UKMi document <a href=\"http://www.evidence.nhs.uk/search?q=%22Which+Vitamin+D+preparations+are+suitable%22\" data-hyperlink-id=\"9dd23390-64b1-44a9-8203-a98c01439821\">Which vitamin D preparations are suitable for a vegetarian or vegan diet?</a> for infomation on suitable preparations.</li><li><strong>For people with halal or kosher requirements,</strong> the UKMi document <a href=\"http://www.evidence.nhs.uk/search?q=%22Which+Vitamin+D+preparations+are+suitable%22\" data-hyperlink-id=\"190256d7-a5ae-470b-ba08-a98c01439919\">Which vitamin D preparations are suitable for a vegetarian or vegan diet?</a> has some information on halal and kosher compliant vitamin D products.</li></ul><!-- end field 4865f39e-fe76-45f7-8fe8-1ec2892cb61c --><!-- end item d86991db-6f75-45f4-bfe3-651f9930b65a -->","subChapters":[]},{"id":"9887654f-f46c-54e7-90fb-e127071e4f55","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field d3c9bb29-6d5a-4447-a0b2-ae1dc4be9bfd --><h3>What are the contraindications and cautions for vitamin D?</h3><!-- end field d3c9bb29-6d5a-4447-a0b2-ae1dc4be9bfd -->","summary":"","htmlStringContent":"<!-- begin item 59204323-882f-44fc-9de1-430fa55d5266 --><!-- begin field aeb5a473-81fd-4dc3-a500-5e8faec1bf04 --><ul><li><strong>Do not prescribe vitamin D preparations to children and young people with:</strong><ul><li>Hypercalcaemia or hypercalciuria (or diseases or conditions which can cause these problems).</li><li>Hypervitaminosis D.</li><li>Nephrolithiasis.</li><li>Severe renal impairment — vitamin D<sub>2</sub> and D<sub>3</sub> are not metabolized normally; other forms of vitamin D should be used.</li></ul></li><li><strong>Prescribe vitamin D with caution to children and young people:</strong><ul><li>With mild to moderate renal impairment.</li><li>With a co-existing condition associated with increased sensitivity to vitamin D (such as sarcoidosis, tuberculosis, lymphoma, or primary hyperparathyroidism) — consider seeking specialist advice.</li><li>Taking <a class=\"topic-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-children/prescribing-information/high-dose-vitamin-d/#drug-interactions\">certain drugs</a>.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-children/references/\">ABPI, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-children/references/\">BNF for Children, 2017</a>]</p><!-- end field aeb5a473-81fd-4dc3-a500-5e8faec1bf04 --><!-- end item 59204323-882f-44fc-9de1-430fa55d5266 -->","subChapters":[]},{"id":"38196cb6-e05a-5727-840a-c3fe7480d7e9","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field daf306f5-b94d-426a-9e38-691dd307324f --><h3>What are the adverse effects of vitamin D?</h3><!-- end field daf306f5-b94d-426a-9e38-691dd307324f -->","summary":"","htmlStringContent":"<!-- begin item 2e09778c-8575-4177-9cf5-7db396d9168a --><!-- begin field f9376d9e-4a2c-401b-93ff-4c6d6ef400e0 --><ul><li><strong>Vitamin D toxicity (which rarely occurs unless the vitamin D dose is very high) manifests mainly through chronic hypercalcaemia, </strong>leading to deposition of calcium in soft tissues, diffuse mineralization of bone, and irreversible renal and cardiovascular toxicity.<ul><li><strong>The clinical features of hypercalcaemia include:</strong><ul><li>Nausea and vomiting.</li><li>Diarrhoea.</li><li>Constipation.</li><li>Anorexia and weight loss.</li><li>Lethargy.</li><li>Polyuria and thirst.</li><li>Sweating.</li><li>Headache.</li><li>Vertigo.</li><li>Raised concentrations of calcium and phosphate in plasma and urine.</li></ul></li><li><strong>If hypercalcaemia is suspected, </strong>check serum calcium levels. If hypercalcaemia is identified:<ul><li>Assess the person's state of hydration, and consider admission if the person is dehydrated.</li><li>If the person is taking a calcium supplement, advise that it should be stopped.</li></ul></li></ul></li><li><strong>Other adverse effects that have been linked with high vitamin D intakes or high serum 25-hydroxyvitamin D (25 [OH]D) concentrations include</strong> an increased incidence of falls and fractures, an increased rates of pancreatic and prostate cancer, and increased total mortality (that is, from all causes combined). However, evidence for these associations is less robust and consistent than that relating to hypercalcaemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-children/references/\">SACN, 2016</a>].</li></ul><p style=\"margin-left:18.0pt;\">[<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-children/references/\">BNF for Children, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-children/references/\">SACN, 2016</a>]</p><!-- end field f9376d9e-4a2c-401b-93ff-4c6d6ef400e0 --><!-- end item 2e09778c-8575-4177-9cf5-7db396d9168a -->","subChapters":[]},{"id":"d26d1758-1d94-56d2-b1c9-ad879da43847","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 05300989-f086-44ce-9c08-e84daf6040ec --><h3>What drug interactions are associated with vitamin D preparations?</h3><!-- end field 05300989-f086-44ce-9c08-e84daf6040ec -->","summary":"","htmlStringContent":"<!-- begin item 6070211a-93f6-40de-8b15-42e07b4a340b --><!-- begin field ece598e3-a230-431d-a00d-76090ab52c78 --><ul><li><strong>The key drug interactions associated with vitamin D are listed below. </strong>Seek specialist advice as appropriate during concurrent treatment with these drugs.<ul><li><strong>Antiepileptic drugs (phenytoin or barbiturates) </strong><strong>—</strong> can increase the metabolism of vitamin D, leading to a reduction in the effects of vitamin D.<ul><li>Higher doses of vitamin D may be needed.  </li></ul></li><li><strong>Cardiac glycosides</strong> <strong>—</strong> excessive dosing of vitamin D can induce hypercalcaemia, which may enhance the effects of digoxin and other cardiac glycosides (leading to an increased risk of digitalis toxicity and serious arrhythmias).<ul><li>Close monitoring (and possibly a dose reduction of vitamin D) is needed during concurrent use.</li></ul></li><li><strong>Corticosteroids —</strong> may increase vitamin D metabolism and elimination.<ul><li>Higher doses of vitamin D may be needed. </li></ul></li><li><strong>Ion exchange resins (such as colestyramine) or laxatives (such as paraffin oil) </strong><strong>—</strong> may reduce the gastrointestinal absorption of vitamin D.<ul><li>Higher doses of vitamin D may be needed.  </li></ul></li><li><strong>Miconazole </strong><strong>—</strong> the effects of vitamin D are possibly reduced by miconazole.<ul><li>Higher doses of vitamin D may be needed.  </li></ul></li><li><strong>Thiazide diuretics</strong> <strong>(such as bendroflumethiazide) —</strong> may reduce the urinary excretion of calcium thereby increasing the risk of hypercalcaemia.<ul><li>Close monitoring (and possibly a dose reduction of vitamin D) is needed during concurrent use. </li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-children/references/\">ABPI, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-children/references/\">BNF for Children, 2017</a>]</p><!-- end field ece598e3-a230-431d-a00d-76090ab52c78 --><!-- end item 6070211a-93f6-40de-8b15-42e07b4a340b -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}